BridgeBio has substantially boosted this course of an new solution for ATTR-CM, leveraging the compound. Initial trial information reveals promising benefits for patients suffering with this severe illness. This effort underscores the company’s focus to managing significant patient demands in the heart arena. Attruby: BridgeBio's Novel … Read More